Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Pleural Effusion I: Introduction

Pleural Effusion I: Introduction

Pleural effusion is an abnormal fluid accumulation in the pleural cavity, a narrow space between the lungs and the chest wall. It is not a disease per se but rather a symptom or indication of an underlying disease. In normal circumstances, this space contains a small amount of fluid (5 to 15 mL), a lubricant facilitating the non-frictional movement of the pleural surfaces.
There are two main types of pleural effusion: transudative and exudative. They are differentiated using Light's...

Pleural Effusion II: Symptoms and Management

Pleural Effusion II: Symptoms and Management

Pleural Effusion Overview
A pleural effusion is the abnormal collection of fluid between the parietal and visceral pleura layers of tissue that form the lining of the lungs and chest cavity. It can occur independently or due to surrounding parenchymal diseases, such as infection, malignancy, or inflammatory conditions.
Clinical Manifestations:

Pneumothorax-II

Pneumothorax-II

Pneumothorax is a medical condition defined by the buildup of air in the pleural space between the lungs and the chest wall. This accumulation of air can lead to partial or complete lung collapse, resulting in a range of clinical manifestations. Understanding the clinical presentation and effective management strategies is crucial for healthcare professionals in providing timely and appropriate care to individuals with pneumothorax.
Clinical Manifestations:

Pneumonia III: Complications and Assessment

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:

Rheumatic Heart Disease I: Introduction

Rheumatic Heart Disease I: Introduction

Rheumatic heart disease or RHD is a chronic condition that results from rheumatic fever, causing permanent damage to the heart valves.Etiology and Risk FactorsIt primarily arises from rheumatic fever, an inflammatory disease that can develop after untreated or inadequately treated group A streptococcal (GAS) pharyngitis. Streptococcus spreads through direct contact with oral or respiratory secretions. While the bacteria are the causative agents, factors like malnutrition, overcrowding, poor...

Pneumonia II: Pathophysiology

Pneumonia II: Pathophysiology

The pathophysiology of pneumonia involves the following steps:

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Endobronchial Valves for Bronchoscopic Lung Volume Reduction in Severe Emphysema: A Reversible and Non-Surgical Treatment for Patients Who May or May Not Be Candidates for Lung Transplantation.

Diagnostics (Basel, Switzerland)·2026

Same author

Periprocedural pain management in pleural disease: a narrative review of current and emerging strategies.

Journal of thoracic disease·2026

Same author

Implementation of a Bedside Percutaneous Dilatational Tracheostomy Program in a Pulmonary and Critical Care Fellowship: Enhancing Patient Safety with a Checklist.

Journal of intensive care medicine·2026

Same author

A 64-Year-Old Man With Ocular Albinism, Interstitial Lung Disease, and Clubbing.

Chest·2026

Same author

Syncope in an Otherwise Healthy 74-Year-Old Woman.

Chest·2024

Same author

Unveiling the Uncommon: Cushing's Syndrome (CS) Masquerading as Severe Hypokalemia.

Cureus·2024

Search research articles

Related Experiment Video

Updated: Aug 31, 2025

Visualization of Streptococcus pneumoniae within Cardiac Microlesions and Subsequent Cardiac Remodeling

Visualization of Streptococcus pneumoniae within Cardiac Microlesions and Subsequent Cardiac Remodeling

Published on: April 7, 2015

Rapidly-Developing Pleural Effusion: Explosive Pleuritis Caused by Group A Streptococcal Infection.

Haris Asif¹, Mateus Fernandes¹, Allen Gorbonos¹

¹Internal Medicine, Woodhull Medical Center, New York City, USA.

|August 22, 2022

Summary

Explosive pleuritis, a rapid progression of parapneumonic effusion, can occur within 24 hours. Group A Streptococcus is a common cause, leading to severe complications and prolonged treatment.

Keywords:

community acquired pneumonia explosive pleuritis exudative pleural effusion rapid pleural effusion streptococcus pyogenes infection

More Related Videos

Implementation of a Permeable Membrane Insert-based Infection System to Study the Effects of Secreted Bacterial Toxins on Mammalian Host Cells

Implementation of a Permeable Membrane Insert-based Infection System to Study the Effects of Secreted Bacterial Toxins on Mammalian Host Cells

Published on: August 19, 2016

Pseudomonas aeruginosa Induced Lung Injury Model

Pseudomonas aeruginosa Induced Lung Injury Model

Published on: October 29, 2014

Related Experiment Videos

Last Updated: Aug 31, 2025

Visualization of Streptococcus pneumoniae within Cardiac Microlesions and Subsequent Cardiac Remodeling

Visualization of Streptococcus pneumoniae within Cardiac Microlesions and Subsequent Cardiac Remodeling

Published on: April 7, 2015

Implementation of a Permeable Membrane Insert-based Infection System to Study the Effects of Secreted Bacterial Toxins on Mammalian Host Cells

Implementation of a Permeable Membrane Insert-based Infection System to Study the Effects of Secreted Bacterial Toxins on Mammalian Host Cells

Published on: August 19, 2016

Pseudomonas aeruginosa Induced Lung Injury Model

Pseudomonas aeruginosa Induced Lung Injury Model

Published on: October 29, 2014

Area of Science:

Infectious Diseases
Pulmonology
Critical Care Medicine

Background:

Community-acquired pneumonia (CAP) is a significant global cause of infectious disease mortality.
Parapneumonic effusion (PPE) is a frequent complication of CAP, potentially progressing to empyema.
Explosive pleuritis, characterized by rapid PPE progression within 24 hours, increases morbidity.

Observation:

Group A Streptococcus (GAS) is a primary pathogen in PPE, associated with higher effusion rates.
A case study details a 30-year-old female with asthma presenting with GAS-related explosive pleuritis.
Initial symptoms included URI, followed by rapid onset of shortness of breath and pleuritic chest pain.

Findings:

Chest X-ray revealed a large, new right-sided pleural effusion.
Pleural fluid culture confirmed Group A Streptococcus as the causative agent.
The patient required prolonged hospitalization, chest tube placement, and failed video-assisted thoracoscopic surgery (VATS).

Implications:

This case underscores the rapid and severe progression of GAS-associated explosive pleuritis.
Challenges in managing such aggressive infections are highlighted.
Effective treatment strategies for explosive pleuritis remain critical in clinical practice.